Love that Patient Power attends ASH. Love that Andrew repeats back and sums up content throughout the program. Really helps! These were excellent guest panelists too. They didn't shy away from the tough questions. Thank you for that!

~Survey comment

Featured Programs

Follicular Lymphoma News at ASH 2018: An Update From Dr. Peter Martin

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Patient Power founder Andrew Schorr is joined by leading expert Dr. Peter Martin to discuss follicular lymphoma treatment news announced at the conference. Watch now to stay up-to-date with the latest research.

Published:

Updates From ASH 2018 Peripheral T-Cell Lymphoma With Dr. Horwitz

Dr. Steven Horwitz joins Lee Swanson to discuss new approvals and advancements made in peripheral T-cell lymphoma at ASH 2018. Dr. Steven Horwitz has been instrumental in these studies leading to approval for new treatments.

Published:

Can Low Clinical Trial Participation Inhibit Cancer Research and Innovation?

Lazarex chairman Dana Dornsife says that there’s a “48 percent failure rate of clinical trials, and it's not because the drug didn't work.” Why do some medicines never make it to market? Watch now to find out.

Published:

The Non-Hodgkin Lymphoma Health Center is sponsored by Kite Pharma.

Advertisement
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog
Advertisement

Page last updated on January 31, 2019